Zeynep Madak Erdogan
LightNews LightNews
banner
zmadake2.bsky.social
Zeynep Madak Erdogan
@zmadake2.bsky.social
1.4K followers 1.9K following 3 posts
Nuclear Receptors, Health Disparities, Metabolism, Sylvia D. Stroup Scholar of Nutrition & Cancer @FSHN_Illinois , Associate Dean @GradCollegeIL, Associate Director of CRTEC @CancerCenterIL, Editor in Chief JES @EndoSocJournals, my opinions only
Posts Replies Media Videos
Reposted by Zeynep Madak Erdogan
mjsikora.bsky.social
If you're wondering, yes, @endocrinesociety.bsky.social will use your pictures for promo material 😂 #ENDO2025

Pretty cool to have @nrimpact.bsky.social folks featured:
@profriggins.bsky.social
@zmadake2.bsky.social
@ayeshashafi.bsky.social
@cittellylab.bsky.social
Drs Cordoba-Chacon & Treviño
Photo of promotional displays, with a picture from the ENDO2024 poster session Photo of the video banner over the registration booths, includes a photo from ENDO2024 of a group of faculty from the NR IMPACT group
July 12, 2025 at 5:54 PM
Reposted by Zeynep Madak Erdogan
endocrinesociety.bsky.social
Notice to Authors with the NIEHS Journal, Environmental Health Perspectives (EHP) | We welcome submissions or transfers of manuscripts now in process at EHP: #JES (Open Access, clinical and basic), and #Endocrinology (basic). Fees can be waived. Email publications@endocrine.org: bit.ly/2yCrRBi
Journals
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
bit.ly
May 7, 2025 at 8:36 PM
Reposted by Zeynep Madak Erdogan
mjsikora.bsky.social
@jostrander.bsky.social and I had the opportunity to write a commentary on @profriggins.bsky.social latest work in JES - @zmadake2.bsky.social - looking toward really cool implications for understanding and leveraging the unique metabolism of lobular breast cancer.

academic.oup.com/jes/advance-...
A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasiv...
Matthew J Sikora, Julie H Ostrander; A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasive lobular carcinoma, Jo
academic.oup.com
January 2, 2024 at 3:24 PM